Legal Opinion
In Re Pfizer Inc. Shareholder Derivative Litigation
District Court, S.D. New York
Decided July 13, 2010No. Master File No.: 09 Civ. 7822 (JSR)PublishedCited by 30 opinions
1Opinion of the Court
OPINION AND ORDER
JED S. RAKOFF, District Judge.
On September 2, 2009, the United States Department of Justice announced that Pfizer, Inc. had agreed to pay $2.3 billion in fines and penalties arising from the illegal “off-label” marketing by Pfizer and one of its subsidiaries of various regulated drugs. Immediately thereafter, several derivative actions were commenced, mostly by institutional investors, seeking recovery on behalf of the company from various senior executives and present and former board members who were alleged to be responsible for the misconduct that resulted in these vary…
2Cases cited30 opinions
- Ashcroft v. IqbalSupreme Court of the United States · 2009
- Kamen v. Kemper Financial Services, Inc.Supreme Court of the United States · 1991
- Aronson v. LewisSupreme Court of Delaware · 1984
- Brehm v. EisnerSupreme Court of Delaware · 2000
- Rales v. Blasband Ex Rel. Easco Hand Tools, Inc.Supreme Court of Delaware · 1993
25 more not listed; retrieve them via the Exa API.
3Cited by30 opinions
- Doubleline Capital LP v. Odebrecht Fin., Ltd.District Court, S.D. Illinois · 2018
- Willa Rosenbloom v. David PyottCourt of Appeals for the Ninth Circuit · 2014
- Sec. & Exch. Comm'n v. Yorkville Advisors, LLCDistrict Court, S.D. Illinois · 2018
- In re Saic Inc. Derivative LitigationDistrict Court, S.D. New York · 2013
- In re Facebook, Inc.District Court, N.D. California · 2019
25 more not listed; retrieve them via the Exa API.